Insulin therapy and fetoplacental vascular function in gestational diabetes mellitus

Experimental Physiology

Volumn 100, Issue 3, 2015, Pages 231-238

  Sobrevia, Luis ^a,b,c   Salsoso, Rocío ^a   Sáez, Tamara ^a   Sanhueza, Carlos ^a   Pardo, Fabián ^a   Leiva, Andrea ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE DERIVATIVE; ADENYLATE CYCLASE; CYCLIC AMP; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; GLUCOSE; GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN; INSULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; SHORT ACTING INSULIN;

BIOLOGICAL ACTIVITY; FETUS CIRCULATION; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INSULIN TREATMENT; PLACENTA; PREGNANCY DIABETES MELLITUS; REVIEW; DIABETES, GESTATIONAL; FEMALE; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACENTA CIRCULATION; PREGNANCY; PRENATAL DIAGNOSIS; PROCEDURES;

DIABETES, GESTATIONAL; FEMALE; HUMANS; INFANT, NEWBORN; INSULIN; PLACENTAL CIRCULATION; PLACENTAL FUNCTION TESTS; PREGNANCY;

EID: 84923547655     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2014.082743     Document Type: Review

References (54)

1. American Diabetes Association (2014). Standards of Medical Care in Diabetes-2014. Diabetes Care 37, S14-S80.
2. Ardiansyah, Shirakawa H, Sugita Y, Koseki T & Komai M (2010). Anti-metabolic syndrome effects of adenosine ingestion in stroke-prone spontaneously hypertensive rats fed a high-fat diet. Br J Nutr 104, 48-55.
3. Barbour LA (2014). Unresolved controversies in gestational diabetes: implications on maternal and infant health. Curr Opin Endocrinol Diabetes Obes 21, 264-270.
4. Bouthoorn SH, Silva LM, Murray SE, Steegers EA, Jaddoe VW, Moll H, Hofman A, Mackenbach JP & Raat H (2014). Low-educated women have an increased risk of gestational diabetes mellitus: the Generation R Study. Acta Diabetol, DOI: 10.1007/s00592-014-0668-x
5. Colomiere M, Permezel M, Riley C, Desoye G & Lappas M (2009). Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus. Eur J Endocrinol 160, 567-578.
6. Cunha RA (2001). Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals. Neurochem Res 26, 979-991.
7. Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF & McDuffie RS; Kaiser Permanente of Colorado GDM Screening Program (2005). Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 28, 579-584.
8. Durnwald CP (2014). Insulin analogues in the treatment of gestational diabetes mellitus. Clin Obstet Gynecol 56, 816-826.
9. Ebina Y, Ellis L, Jarnagin K, Edery M, Graf L, Clauser E, Ou J-H, Masiarz F, Kan YW, Goldfine ID, Roth RA & Rutter WJ (1985). The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell 40, 747-758.
10. Eltzschig HK (2009). Adenosine: an old drug newly discovered. Anesthesiology 111, 904-915.
11. 2B adenosine receptors in placenta microvascular endothelial cells from pre-eclampsia. Placenta 29, 816-825.
12. Farías M, San Martín R, Puebla C, Pearson JD, Casado JF, Pastor-Anglada M, Casanello P & Sobrevia L (2006). Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes. J Cell Physiol 208, 451-460.
13. Ferrara A, Kahn HS, Quesenberry CP, Riley C & Hedderson MM (2004). An increase in the incidence of gestational diabetes mellitus: Northern California, 1991-2000. Obstet Gynecol 103, 526-533.
14. Fleming I (2010). Molecular mechanisms underlying the activation of eNOS. Pflugers Arch 459, 793-806.
15. Fox SB & Khong TY (1990). Lack of innervation of human umbilical cord. An immunohistological and histochemical study. Placenta 11, 59-62.
16. Frasca F, Pandini G, Malaguarnera R, Mandarino A, Messina RL, Sciacca L, Belfiore A & Vigneri R (2007). Role of c-Abl in directing metabolic versus mitogenic effects in insulin receptor signaling. J Biol Chem 282, 26077-26088.
17. Fredholm BB (2011). Adenosine-a physiological or pathophysiological agent? J Mol Med (Berl) 92, 201-206.
18. Fredholm BB, IJzerman AP, Jacobson KA, Linden J & Müller CE (2014). International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors-an update. Pharmacol Rev 63, 1-34.
19. Guzmán-Gutiérrez E, Arroyo P, Pardo F, Leiva A & Sobrevia L (2013). The adenosine-insulin signalling axis in the fetoplacental endothelial dysfunction in gestational diabetes. In Gestational Diabetes - Causes, Diagnosis and Treatment, ed. Sobrevia L, pp. 49-78. InTech Editorial, Rijeka, Croatia.
20. Guzmán-Gutiérrez E, Arroyo P, Salsoso R, Fuenzalida B, Sáez T, Leiva A, Pardo F & Sobrevia L (2014). Role of insulin and adenosine in the human placenta microvascular and macrovascular endothelial cell dysfunction in GDM. Microcirculation 21, 26-37.
21. 2A adenosine receptors activation in human umbilical vein endothelium. PLoS ONE 7, e41705.
22. Haas TL (2014). Shaping and remodeling of the fetoplacental circulation: aspects of health and disease. Microcirculation 21, 1-3.
23. Hickman MA, McBride R, Boggess KA & Strauss R (2013). Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. Am J Perinatol 30, 483-490.
24. Hiden U, Lang I, Ghaffari-Tabrizi N, Gauster M, Lang U & Desoye G (2009). Insulin action on the human placental endothelium in normal and diabetic pregnancy. Curr Vasc Pharmacol 7, 460-466.
25. Hiersch L & Yogev Y (2014). Management of diabetes and pregnancy - when to start and what pharmacological agent to choose? Best Pract Res Clin Obstet Gynaecol S1521, 1-12.
26. Hunt KJ & Conway DL (2008). Who returns for postpartum glucose screening following gestational diabetes mellitus? Am J Obstet Gynecol 198, 404.e1-404.e6.
27. Jacobson KA & Gao ZG (2006). Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5, 247-64.
28. Kärkkäinen H, Laitinen T, Heiskanen N, Saarelainen H, Valtonen P, Lyyra-Laitinen T, Vanninen E & Heinonen S (2013). Need for insulin to control gestational diabetes is reflected in the ambulatory arterial stiffness index. BMC Pregnancy Childbirth 13, 9-16.
29. König AB, Junginger S, Reusch J, Louwen F & Badenhoop K (2014). Gestational diabetes outcome in a single center study: higher BMI in children after six months. Horm Metab Res 46, 804-809.
30. Lappas M (2014). NOD1 expression is increased in the adipose tissue of women with gestational diabetes. J Endocrinol 222, 99-112.
31. Leach L (2011). Placental vascular dysfunction in diabetic pregnancies: intimations of fetal cardiovascular disease? Microcirculation 18, 263-269.
32. Leiva A, Pardo F, Ramírez MA, Farías M, Casanello P & Sobrevia L (2011). Fetoplacental vascular endothelial dysfunction as an early phenomenon in the programming of human adult diseases in subjects born from gestational diabetes mellitus or obesity in pregnancy. Exp Diabetes Res 2011, 349286.
33. Löbner K, Knopff A, Baumgarten A, Mollenhauer U, Marienfeld S, Garrido-Franco M, Bonifacio E & Ziegler AG (2006). Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 55, 792-797.
34. Maguire MH, Szabó I, Valkó IE, Finley BE & Bennett TL (1998). Simultaneous measurement of adenosine and hypoxanthine in human umbilical cord plasma by reversed-phase high-performance liquid chromatography with photodiode-array detection and on-line validation of peak purity. J Chromatogr B Biomed Sci Appl 707, 33-41.
35. Marzioni D, Tamagnone L, Capparuccia L, Marchini C, Amici A, Todros T, Bischof P, Neidhart S, Grenningloh G & Castellucci M (2004). Restricted innervation of uterus and placenta during pregnancy: evidence for a role of the repelling signal Semaphorin 3A. Dev Dyn 231, 839-848.
36. Metzger BE, Buchanan TA, Coustan DR, deLeiva A, Dunger DB, Hadden DR, Hod M, Kitzmiller JL, Kjos SL, Oats JN, Pettitt DJ, Sacks DA & Zoupas C (2007). Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 30, S251-S260.
37. Mundell S & Kelly E (2010). Adenosine receptor desensitization and trafficking. Biochim Biophys Acta 1808, 1319-1328.
38. Norman RJ, Wang JX & Hague W (2004). Should we continue or stop insulin sensitizing drugs during pregnancy? Curr Opin Obstet Gynecol 16, 245-250.
39. Olmos PR, Araya-Del-Pino AP, González-Carvello CA, Laso-Ulloa P, Hodgson MI, Irribarra V, Borzone GR, Belmar C, Poblete A, Berríos C, Becker J, Zajer-Amar CM, Manzur A, Bozinovic M, Miranda RJ, Diez A, Vidal H, Ramírez-Armijo R, Olmos RI, Tabilo C & Ahuad J (2009). Near-optimal glycemic control in Chilean women with pregestational type-2 diabetes: persistent macrosomia relates to maternal pre-pregnancy overweight. Diabetes Res Clin Pract 85, 53-60.
40. Olsson RA & Pearson JD (1990). Cardiovascular purinoceptors. Physiol Rev 70, 761-845.
41. Pardo F, Arroyo P, Salomón C, Westermeier F, Salsoso R, Sáez T, Guzmán-Gutiérrez E, Leiva A & Sobrevia L (2013). Role of equilibrative adenosine transporters and adenosine receptors as modulators of the human placental endothelium in gestational diabetes mellitus. Placenta 34, 1121-1127.
42. Pearson JD & Gordon JL (1985). Nucleotide metabolism by endothelium. Annu Rev Physiol 47, 617-627.
43. Rowan JA, Hague WM, Gao W, Battin MR & Moore MP; MiG Trial Investigators (2008). Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 358, 2003-2015.
44. Salomón C, Westermeier F, Puebla C, Arroyo P, Guzmán-Gutiérrez E, Pardo F, Leiva A, Casanello P & Sobrevia L (2012). Gestational diabetes reduces adenosine transport in human placental microvascular endothelium, an effect reversed by insulin. PLoS ONE 7, e40578.
45. Salsoso R, Guzmán-Gutiérrez E, Sáez T, Bugueño K, Ramírez MA, Farías M, Pardo F, Leiva A, Sanhueza C, Mate A, Vázquez C, Sobrevia L (2015). Insulin restores L-arginine transport requiring adenosine receptors activation in umbilical vein endothelium from late-onset preeclampsia. Placenta, DOI: 10.1016/j.placenta.2014.12.007
46. San Martín R & Sobrevia L (2006). Gestational diabetes and the adenosine/l-arginine/nitric oxide (ALANO) pathway in human umbilical vein endothelium. Placenta 27, 1-10.
47. Sheth S, Brito R, Mukherjea D, Rybak LP & Ramkumar V (2014). Adenosine receptors: expression, function and regulation. Int J Mol Sci 28, 2024-2052.
48. Sobrevia L, Abarzúa F, Nien JK, Salomón C, Westermeier F, Puebla C, Cifuentes F, Guzmán-Gutiérrez E, Leiva A & Casanello P (2011). Review: Differential placental macrovascular and microvascular endothelial dysfunction in gestational diabetes. Placenta 32, S159-S164.
49. Vergauwen L, Hespel P & Richter EA (1994). Adenosine receptors mediate synergistic stimulation of glucose uptake and transport by insulin and by contractions in rat skeletal muscle. J Clin Invest 93, 974-981.
50. Verier-Mine O (2010). Outcomes in women with a history of gestational diabetes. Screening and prevention of type 2 diabetes. Literature review. Diabetes Metab 36, 595-616.
51. Verkhratsky A & Burnstock G (2014). Biology of purinergic signalling: its ancient evolutionary roots, its omnipresence and its multiple functional significance. Bioessays 36, 697-705.
52. Westermeier F, Salomón C, Farías M, Arroyo P, Fuenzalida B, Sáez T, Salsoso R, Sanhueza C, Guzmán-Gutiérrez E, Pardo F, Leiva A & Sobrevia L (2015). Insulin requires normal expression and signaling of insulin receptor A to reverse gestational diabetes-reduced adenosine transport in human umbilical vein endothelium. FASEB J 29, 37-49.
53. Westermeier F, Salomón C, González M, Puebla C, Guzmán-Gutiérrez E, Cifuentes F, Leiva A, Casanello P & Sobrevia L (2011). Insulin restores gestational diabetes mellitus-reduced adenosine transport involving differential expression of insulin receptor isoforms in human umbilical vein endothelium. Diabetes 60, 1677-1687.
54. Wyatt AW, Steinert JR, Wheeler-Jones CP, Morgan AJ, Sugden D, Pearson JD, Sobrevia L & Mann GE (2002). Early activation of the p42/p44 MAPK pathway mediates adenosine-induced NO production in human endothelial cells: a novel calcium-insensitive mechanism. FASEB J 16, 1584-1594.